<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04161716</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02770-57</org_study_id>
    <nct_id>NCT04161716</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)</brief_title>
  <acronym>DETTECH</acronym>
  <official_title>Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioSerenity</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioSerenity</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      NIRS technology is therefore a technique that exploits the different absorption properties of&#xD;
      oxygenated and deoxygenated hemoglobin to evaluate the degree of tissue oxygenation. This&#xD;
      hemodynamic response is measured in a completely non-invasive and silent manner, by the&#xD;
      simple emission of light passing through different layers of biological tissue.&#xD;
&#xD;
      In the literature, some studies concerning the use of the NIRS method for the study of&#xD;
      urodynamics exist. They seem to show a correlation between the data of the urodynamic&#xD;
      assessment and the data obtained with the NIRS method. Certain trends seem to be repeated&#xD;
      with, for example, an increase in oxyhemoglobin at the beginning of the filling phase and the&#xD;
      beginning of the urination phase.&#xD;
&#xD;
      The aim of the study is to analyze the NIRS signal and find correlation with urodynamic data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to detect a urodynamic variation of the detrusor muscle during a&#xD;
      contraction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>NIRS module recording</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>9 months</time_frame>
    <description>concentrations of oxygenated O2Hb, provided from a NIRS module</description>
  </primary_outcome>
  <primary_outcome>
    <measure>detrusor pressure measurement (Pdet)</measure>
    <time_frame>1 hour</time_frame>
    <description>Pdet during filling and emptying of the urodynamic exam</description>
  </primary_outcome>
  <primary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>9 months</time_frame>
    <description>concentrations of deoxygenated HHb, provided from NIRS module</description>
  </primary_outcome>
  <primary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>9 months</time_frame>
    <description>concentrations of total tHB provided from NIRS module</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>9 months</time_frame>
    <description>concentrations of oxygenated O2Hb, provided from NIRS module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>detrusor pressure measurement (Pdet)</measure>
    <time_frame>1 hour</time_frame>
    <description>Pdet during filling and emptying of the urodynamic exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>1 hour</time_frame>
    <description>concentrations of deoxygenated HHb, provided from NIRS module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical annotations of the doctor performed on the report of the urodynamic exam</measure>
    <time_frame>1 hour</time_frame>
    <description>Normality of detrusor function (YES/NO), hyperactive detrusor function (YES/NO) , hypoactive detrusor function (YES/NO).&#xD;
Criteria assessed by the investigator by a response (yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>optical measurement of hemoglobin concentrations</measure>
    <time_frame>9 months</time_frame>
    <description>concentrations of total tHB provided from NIRS module</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Urinary Disorders</condition>
  <condition>Urinary Incontinence</condition>
  <condition>Urinary Bladder Diseases</condition>
  <arm_group>
    <arm_group_label>NIRS module</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient has a NIRS module during a diagnosis urodynamic assessment provided for by the usual practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIRS recording</intervention_name>
    <description>Patient has a NIRS module during their urodynamic exam.</description>
    <arm_group_label>NIRS module</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Person whose urodynamic evaluation for diagnosis purposes is necessary&#xD;
&#xD;
          -  Male or female â‰¥ 18 years&#xD;
&#xD;
          -  Person affiliated with a social security scheme&#xD;
&#xD;
          -  ECBU / BU negative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors&#xD;
&#xD;
          -  Pregnant or parturient or lactating women&#xD;
&#xD;
          -  Refusal of consent&#xD;
&#xD;
          -  Contraindications usually provided for the realization of a Urodynamic exam&#xD;
&#xD;
          -  Sensory disturbances making the participant insensitive to pain&#xD;
&#xD;
          -  Motor or mental disorders that prevent the participant from expressing pain&#xD;
&#xD;
          -  Behavioral problems that make the participant excessively agitated or aggressive&#xD;
&#xD;
          -  Irritation and / or erythema, or open sore in the area covered by the NIRS&#xD;
&#xD;
          -  Half-sitting position impossible&#xD;
&#xD;
          -  Tattoo or stretch mark in the lower abdomen or pubic area&#xD;
&#xD;
          -  External cutaneous or internal scar in the area covered by the NIRS&#xD;
&#xD;
          -  Allergy to a component of the textile part of the device: polyamide, cotton,&#xD;
             polyester, elastane, silver, other synthetic materials&#xD;
&#xD;
          -  Simultaneous participation in another search&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>half of women and half of men</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rangueil Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 5, 2019</study_first_submitted>
  <study_first_submitted_qc>November 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2019</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urodynamic</keyword>
  <keyword>bladder</keyword>
  <keyword>detrusor</keyword>
  <keyword>urinary disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Bladder Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

